mTOR, mammalian target of rapamycin
The injection contains a form of vitamin B12, usually hydroxocobalamin
As of April 2026, BPC-157 is on the FDA's 503A Category 2 list
The products of this company are not intended to diagnose, treat, cure, or prevent any medical condition or disease
2 Otoprotection in Zebrafish Lateral Line Hair Cells Uribe et al., Frontiers in Cellular Neuroscience (2015) This paper from the Coffin laboratory (with WSU co-authors) tested whether Dihexa could protect zebrafish lateral line hair cells (homologous to mammalian inner ear hair cells) from aminoglycoside-induced ototoxicity
Acknowledgments None of the co-authors declare a conflict of interest with LifeVantage Corporation with the exception that they funded principal investigator G.S.Z to perform the study